Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss. Improving distant control of lung cancer is the most exciting potential benefit of combining ...

ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...

It’s a bad day when a doctor says you have cancer. It’s a worse day when he says it’s stage prostate cancer with a metastatic ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal ...

Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer ...

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer ...